BioAlberta News

Cyplasin Biomedical is a product-oriented, specialty pharmaceutical company focused on developing products for the multi-billion dollar hepatitis C virus (HCV) market. The Company is pleased to announce it has secured US$10M in financing under an equity line of credit (ELOC) with Tangiers Investors, LP to fund the Company's operations and product development programs.

 
Wednesday, July 28, 2010 - 09:13
Legal firms say Canada's life sciences industry will survive the current economic crunch and prosper, in spite of access to capital.
 

Read full press release details.

Friday, July 23, 2010 - 08:52
Ceapro Inc. (TSX VENTURE: CZO.V) is pleased to announce today the completion of a new marketing partnership and distribution agreement with UK firm, Oat Cosmetics Ltd. The agreement encompasses all of Ceapro's current range of all-natural active ingredients.
 
Friday, July 16, 2010 - 15:04
June 30, 2010 - Innovotech Inc. (TSX VENTURE:IOT), a pioneer in the field of biofilm product development, has secured funding in excess of $900,000 from Agriculture and Agri-Food Canada to facilitate the commercialization of Agress™, its unique, environmentally friendly seed treatment and plant spray designed to protect crops against both bacterial and fungal infections.
 
Friday, July 16, 2010 - 15:01

BioMS Medical Corp. shareholders approved a motion to change the company's name to Medwell Capital Corp. at the Company’s annual meeting held on 25 June 2010.

Read full details of press release.

 

Monday, July 12, 2010 - 09:40

CEAPRO Inc. announced the completion of a new marketing partnership and distribution agreement with UK firm, Oat Cosmetics Ltd. The agreement encompasses all of Ceapro's current range of all-natural active ingredients.

Read detail of press release here.

Thursday, June 24, 2010 - 15:23
SciMed Technologies Inc. announces they received certification from the AOAC International - a worldwide scientific association dedicated to analytical excellence - for VitaKit A(R) the world's first 2 hour rapid test for accurate analysis of vitamin A in liquid milk.
 
 
Thursday, June 10, 2010 - 14:04

Alberta Enterprise, a fund of funds manager investing in knowledge-based industries, investments brings leading clean energy venture capital firm to Alberta in and improves access to capital in information technology and clean tech sectors.

For details, follow links below:

Thursday, June 3, 2010 - 09:51

CALGARY, ALBERTA--(Marketwire - May 25, 2010) - Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) announced today the top-line results for the modified REGENESIS-Phase IIb stroke trial. The modified REGENESIS- Phase IIb trial, a placebo controlled, double blinded, 3:1 randomized clinical study, enrolled 96 patients with acute ischemic stroke between August 2009 and January 24, 2010.

Wednesday, May 26, 2010 - 08:55